Rogue Investor

Amgen Stock Information

Company Information

Amgen, Inc. is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. In July 2002, the Company completed its acquisition of Immunex Corporation, a biotechnology company dedicated to developing immune system science to protect human health. The Company markets human therapeutic products including Epogen (Epoetin alfa), Aranesp (darbepoetin alfa), Neupogen (Filgrastim), Neulasta (pegfilgrastim) and Kineret (anakinra). Amgen acquired the rights to Enbrel (etanercept) as a result of the Immunex acquisition. Enbrel is marketed with Wyeth under a co-promotion agreement. 

What is the stock symbol for Amgen? AMGN

Click here for the current Amgen stock price.

Is this stock a good buy? 

Ask the Rogue Investor....

Rogue Investor Audio Book


The Rogue Investor ebook is the only information on investing I've ever found that was useful and understandable. I enjoyed its format and its brevity. I'm not sure what improvements there would be to make on the book. It is something everyone should read whether or not they are interested in serious investing. Thank you very much!

- Kevin Davis

Are you tired of investing 
in the stock market? 

You can safely earn 18 to 50 percent 
per year investing in government-
sponsored tax lien certificates.

Rogue Tax Lien Investor



I wanted to let you know that I've spent the last several hours reading [your book] and I'm having a great time with it. It's a terrific read and you should be complimented with the care and detail you've put into it.


Thank you very much,


Rob Durstewitz



HomeSample ChapterTestimonialsAuthor InfoAbout OrderingPurchasefaqs
  Investing ReportArticlesResearch StocksInvesting Resources • 
Real Estate Definitions

Rogue Investor ( )
Copyright 2000 - 2004, Mind Like Water, Inc., 7419 Metcalf Ave. #321, Overland Park, KS 66204
(913) 381-4520,